$INSY Initiates Five Phase III Clinical Trials

Insys Therapeutics to Initiate Five Phase III Clinical Trials in 2015 PHOENIX,…

$OXIS Announces Exclusive Licensing for “P62 Chemical Agents and Multiple Myeloma Therapeutics”

Oxis Biotech Executes Worldwide Exclusive Patent Licensing “P62 Chemical Agents and Multiple…

$CHUM Issues Caution to Investors RE: Unauthorized Investor Relations Campaigns

Chuma Holdings Cautions Investors Regarding Unauthorized Investor Relations Campaigns LOS ANGELES, CA…

$MDBX Adds New Directions and Unveils Board Advisory Committee

Medbox Founder Votes to ‘Lean-Out’ Director and Officer Compensation Founder Announces Formation…

$PLPL Talks Company Plans for 2015

Plandai Biotechnology, Inc.’s CEO Discusses Company’s Plans for 2015 NEW YORK, NY–(Marketwired…

$SRNA Announces Agreement to Aquire Top Cannabis Seed-to-Sale Tracking Platform

Surna Inc. To Acquire Majority Interest in Agrisoft Development Group, a Leading…

$MDBX and Others Under Investigation by Lifshitz & Miller Law Frim

Lifshitz & Miller Law Firm Announces Investigation of DaVita HealthCare Partners Inc.,…